• to reduced the risk of major cardiovascular (heart and blood vessel) issues in Grown ups with style 2 diabetes and heart problemsThis led Novo Nordisk to carry out more investigate into higher dosages of semaglutide especially for weight administration.A November 2014 newspaper posting, proposed that a new professional medical analysis breakthr